BFRI Biofrontera Inc.

NASDAQ
$0.89

Biofrontera Inc. (BFRI) is confirmed to report earnings on November 13, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -30.1% since its last earnings release on August 13, 2026.

Biofrontera Beat Consensus Estimates
Thursday, August 13, 2026 · 8:51 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · 8:50 AM ET
Earnings Whisper
-
vs -
Rev est $8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.29

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.